Digital Biomarkers & Digital Measurements Summit | 9th-10th March 2022 | Virtual, GMT Timezone

2:25 pm GMT Why is Real World Walking Speed so important as a Digital Biomarker in Movement-related Disorders? - The experience with outcome measures in MS trials - Dialogue with EMA & FDA about regulatory acceptance, including MDR/GDPR - The future: Cloud computing, multi-sensor tools and understandable AI

Martin Daumer, Scientific Director | Honorary Professor, Sylvia Lawry Centre for Multiple Sclerosis | Technical University of Munich